Sunday, November 15, 2026

Peer-Reviewed Clinical Evidence Platform

The research that matters, without the jargon.

Peer-reviewed breakthroughs in plain English alongside verified outcomes, evidence grades, and clinical study details for everyone from everyday readers to medical students.

ClearMed Editorial Digest500 briefings across 12 specialties121 Phase III & clinical practice

Indexed from PubMed, NEJM, The Lancet, JAMA, Nature MedicineSaved Library

Health Hubs:

Stage: Evidence:

Showing 23 briefings

Reset all filters

Pharmacology

Pharmacology Clinical Briefings

Peer-Reviewed Clinical Digests · Verified Scientific Media

PHARMACOLOGY · CLINICAL PRACTICE

Diet, Exercise, Drugs, Not Supplements, Slow Biological Aging

To truly slow your biological clock, prioritize healthy living and evidence-based medicine over unproven anti-aging supplements. This comprehensive review challenges a common belief that expensive, often unproven supplements are the key to unlocking longevity.

4/5 Strong Trial

Evidence Meter · 4/5

Strong Clinical Evidence

Tested directly in patients through a prospective clinical trial or large multicenter human cohort.

1 min readScienceDailyNov 14, 2026

PHARMACOLOGY · CLINICAL PRACTICE

Explosive Sports Show Superior Bone-Building Efficacy Over Traditional Exercise

High-impact, multi-directional sports may offer a significantly superior osteogenic stimulus compared to conventional weight-bearing or resistance exercises, potentially improving osteoporosis prevention strategies. Current clinical guidelines for maintaining bone health and preventing osteoporosis frequently recommend weight-bearing activities such as walking, jogging, and progressive resistance training.

3/5 Observational

Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readScienceDailyNov 12, 2026

PHARMACOLOGY · CLINICAL PRACTICE

Enamel Regeneration Gel: A New Era for Dental Health

An experimental gel shows promise in regenerating tooth enamel, offering a potential future treatment to prevent cavities and repair dental damage by harnessing natural salivary minerals. This development could revolutionize dentistry by offering a simple, non-invasive method to repair damaged teeth, preventing future decay and reducing sensitivity.

3/5 Observational

Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readScienceDailyNov 12, 2026

PHARMACOLOGY · PRECLINICAL

Novel Compound Creates 'Super HGF' to Boost Muscle Repair in Aging

A new compound's ability to create a 'Super HGF' represents a potential pharmacological strategy to counteract age-related muscle degradation. This breakthrough offers a promising new approach to combat age-related muscle loss, known as sarcopenia, which significantly impacts mobility and independence.

2/5 Preclinical

Evidence Meter · 2/5

Animal & Preclinical Data

Demonstrated in living animal models before large-scale human safety and dosing trials begin.

1 min readScienceDailyNov 12, 2026

PHARMACOLOGY · PRECLINICAL

Electric Implant: Novel Glucose Control and Weight Loss for Type 2 Diabetes

An electronic implant effectively lowered blood sugar and promoted weight loss in diabetic mice by converting excess glucose for urinary excretion. This breakthrough offers a potential new paradigm for type 2 diabetes management, particularly for patients who struggle with current insulin or drug regimens.

2/5 Preclinical

Evidence Meter · 2/5

Animal & Preclinical Data

Demonstrated in living animal models before large-scale human safety and dosing trials begin.

1 min readScienceDailyNov 12, 2026

PHARMACOLOGY · REAL-WORLD COHORT

Moderate Alcohol Intake Linked to Elevated Cancer and Mortality Risk

Even moderate alcohol consumption shows no health benefits and is linked to increased risks of cancer, heart disease, and early risk of death. This finding has critical implications for public health recommendations and patient counseling regarding alcohol intake.

3/5 Observational

Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readScienceDailyNov 12, 2026

PHARMACOLOGY · REAL-WORLD COHORT

New Review Finds Weak Evidence for Medical Cannabis as a Sleep Aid

Despite growing interest, robust clinical evidence for medical cannabis improving sleep remains largely absent. This doesn't definitively rule out cannabis as a sleep aid but highlights the urgent need for rigorous clinical trials before widespread recommendation.

3/5 Observational

Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readScienceDailyNov 12, 2026

PHARMACOLOGY · REAL-WORLD COHORT

Intensive Lifestyle Reverses Type 2 Diabetes in Younger Adults

Lifestyle intervention combining diet and exercise can induce type 2 diabetes remission in over half of younger adults, presenting a powerful alternative to lifelong medication. This breakthrough highlights a potent non-pharmacological pathway to potentially reverse type 2 diabetes, especially in younger populations.

3/5 Observational

Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readScienceDailyNov 12, 2026

PHARMACOLOGY · REAL-WORLD COHORT

The expansion of kinase drug discovery: new targets, platforms and indications

We also examine the features associated with successful kinase-targeting agents and causes of agent discontinuations and regulatory withdrawal. Nevertheless, development remains highly concentrated around a small set of blockbuster kinase targets, such as EGFR.

4/5 Strong Trial

Evidence Meter · 4/5

Strong Clinical Evidence

Tested directly in patients through a prospective clinical trial or large multicenter human cohort.

1 min readNature Reviews Drug DiscoveryNov 11, 2026

PHARMACOLOGY · PHASE I/II

HOPO 14-1, an Oral Actinide Chelator: A Phase 1 Nonrandomized Clinical Trial

Single oral doses of HOPO 14-1 up to 7500 mg were given without dose-limiting toxicity or serious side effects in healthy adults. Gastrointestinal tolerability defined the practical single-dose ceiling.

5/5 Gold Standard

Evidence Meter · 5/5

Gold-Standard Human Evidence

Backed by randomized controlled human trials or a formal meta-analysis pooling multiple clinical studies.

1 min readJAMANov 11, 2026

PHARMACOLOGY · REAL-WORLD COHORT

Histone lysine demethylases in the third decade: biology and therapeutic prospects

We highlight the need for more potent and selective KDM inhibitors, biomarkers of therapeutic response, novel combinatorial treatments and innovative drug discovery strategies. As we enter the third decade of investigations into histone demethylation, unlocking the full therapeutic potential of inhibiting KDMs will require a deeper understanding of their biology, substrate specificity, interaction networks and regulatory crosstalk.

3/5 Observational

Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readNature Reviews Drug DiscoveryNov 9, 2026

PHARMACOLOGY · PHASE III

Orforglipron for Obstructive Sleep Apnea: Results From 2 Randomized Clinical Trials (ATTAIN-OSA)

These results provide evidence for the potential use of oral orforglipron to improve sleep-disordered breathing in adults with moderate to severe OSA and obesity or overweight. To assess the effects of orforglipron on moderate to severe OSA in adults with obesity or overweight, compared with placebo (inactive comparison treatment).

5/5 Gold Standard

Evidence Meter · 5/5

Gold-Standard Human Evidence

Backed by randomized controlled human trials or a formal meta-analysis pooling multiple clinical studies.

1 min readJAMANov 9, 2026

Showing 12 of 23 medical briefings

Interactive Fact Check